Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels

被引:128
作者
Boizel, R
Benhamou, PY
Lardy, B
Laporte, F
Foulon, T
Halimi, S
机构
[1] Univ Hosp, Dept Endocrinol Diabetol Nutr, F-38043 Grenoble, France
[2] Univ Hosp, Dept Biochem, Grenoble, France
关键词
D O I
10.2337/diacare.23.11.1679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - In patients with type 2 diabetes, a normal HDL cholesterol level does not rule out that LDL particles may be small. Although techniques for analyzing LDL subfractions are not likely to be used in clinical practice, a prediction of LDL size based on a regular lipid profile may be useful for assessment of cardiovascular risk. RESEARCH DESIGN AND METHODS - Sixty patients with type 2 diabetes with acceptable glycemic control and an HDL cholesterol level greater than or equal to1 mmol/l were recruited after cessation of lipid-altering treatments. LDL size was determined by 2-20% PAGE; patients having small LDL (n = 30) were compared with those having intermediate or large LDL (n = 30). RESULTS - Clinical characteristics, pharmacological therapies, lifestyle, and prevalence of diabetes-related complications were similar in both patient groups. LDL size correlated negatively with plasma triglycerides (TGs) (R-2 = 0.52) and positively with HDL cholesterol (R-2 = 0.14). However, an inverse correlation between the TG-to-HDL cholesterol molar ratio and LDL size was even stronger (R-2 = 0.59). The ratio was >1.33 in 90% of the patients with small LDL particles (95% CI 79.3-100) and 16.5% of those with larger LDI particles. A cutoff point of 1.33 for the TG-to-HDL cholesterol ratio distinguishes between patients having small LDI values better than TG cutoff of 1.70 and 1.45 mmol/l. CONCLUSIONS - The TG-to-HDL cholesterol ratio may be related to the processes involved in LDL size pathophysiology and relevant with regard to the risk of clinical vascular disease. It may be suitable for the selection of patients needing an earlier and aggressive treatment of lipid abnormalities.
引用
收藏
页码:1679 / 1685
页数:7
相关论文
共 31 条
  • [1] ABNORMAL CHOLESTEROL DISTRIBUTION AMONG LIPOPROTEIN FRACTIONS IN NORMOLIPIDEMIC PATIENTS WITH MILD NIDDM
    ABATE, N
    VEGA, GL
    GARG, A
    GRUNDY, SM
    [J]. ATHEROSCLEROSIS, 1995, 118 (01) : 111 - 122
  • [2] Alberti KGGM, 1999, DIABETIC MED, V16, P352
  • [3] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK
    AUSTIN, MA
    KING, MC
    VRANIZAN, KM
    KRAUSS, RM
    [J]. CIRCULATION, 1990, 82 (02) : 495 - 506
  • [4] Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients
    Caixas, A
    OrdonezLlanos, J
    deLeiva, A
    Payes, A
    Homs, R
    Perez, A
    [J]. DIABETES, 1997, 46 (07) : 1207 - 1213
  • [5] LDL PARTICLE-SIZE DISTRIBUTION - RESULTS FROM THE FRAMINGHAM OFFSPRING STUDY
    CAMPOS, H
    BLIJLEVENS, E
    MCNAMARA, JR
    ORDOVAS, JM
    POSNER, BM
    WILSON, PWF
    CASTELLI, WP
    SCHAEFER, EJ
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12): : 1410 - 1419
  • [6] DIFFERENCES IN POSTPRANDIAL LIPEMIA BETWEEN PATIENTS WITH NORMAL GLUCOSE-TOLERANCE AND NONINSULIN-DEPENDENT DIABETES-MELLITUS
    CHEN, YDI
    SWAMI, S
    SKOWRONSKI, R
    COULSTON, A
    REAVEN, GM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) : 172 - 177
  • [7] Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: A multicenter study
    Delcourt, C
    Vauzelle-Kervroedan, F
    Cathelineau, G
    Papoz, L
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1998, 12 (02) : 88 - 95
  • [8] LDL SUBCLASS PHENOTYPES AND TRIGLYCERIDE-METABOLISM IN NON-INSULIN-DEPENDENT DIABETES
    FEINGOLD, KR
    GRUNFELD, C
    PANG, MY
    DOERRLER, W
    KRAUSS, RM
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12): : 1496 - 1502
  • [9] GAMBERT P, 1990, J LIPID RES, V31, P1199
  • [10] Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction
    Gaziano, JM
    Hennekens, CH
    ODonnell, CJ
    Breslow, JL
    Buring, JE
    [J]. CIRCULATION, 1997, 96 (08) : 2520 - 2525